← back to search

Junqiang Chen

Shandong University · CN
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes, Head and Neck Cancer Studies, and Lung Cancer Diagnosis and Treatment.
h-index
22
citations
1,543
works
170
NIH funding
primary concept
email

Recent publications

Prevalence of malnutrition among adult inpatients in China: a nationwide cross-sectional study
Science China Life Sciences 2025cited by 7position: middledoi
China Anti-Cancer Association (CACA) guidelines for treating cancer-related malnutrition
Holistic Integrative Oncology 2025cited by 3position: middledoi
Development of a prognostic nomogram and risk stratification system for elderly patients with esophageal squamous cell carcinoma undergoing definitive radiotherapy: a multicenter retrospective analysis (3JECROG R-03 A)
BMC Cancer 2025cited by 3position: lastdoi
Long-term outcomes of S-1-based chemoradiotherapy in inoperable elderly patients with esophageal carcinoma: A multicenter, randomized, phase III clinical trial
Radiotherapy and Oncology 2025cited by 1position: firstdoi
Comparative analysis of immunochemotherapy with versus without radiation therapy for stage IVB esophageal squamous cell carcinoma confined to non-regional nodal metastases: a multicenter propensity score matching study
Cancer Immunology Immunotherapy 2025cited by 0position: middledoi
High-Dose Radiotherapy for Cervical and Upper Thoracic Esophageal Cancer: A Multicenter Real-World Study with Dose-Benefit Exploration
Research Square 2025cited by 0position: middledoi
Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study
Therapeutic Advances in Medical Oncology 2024cited by 3position: middledoi
Dose escalation in radical radio(chemo)therapy for cervical and upper thoracic esophageal cancer with 3DCRT/IMRT (ChC&UES): a multicenter retrospective study
Radiation Oncology 2024cited by 3position: middledoi
Dose Escalation in Radical Radio(chemo)therapy for Cervical and Upper Thoracic Esophageal Cancer with 3DCRT/IMRT (ChC&UES): A Multi-center Real world Study
Research Square 2024cited by 0position: middledoi
Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial
˜The œLancet. Gastroenterology & hepatology 2023cited by 72position: middledoi
Effectiveness of S-1–Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma
JAMA Network Open 2023cited by 27position: middledoi
Quality of life and survival outcomes of patients with inoperable esophageal squamous cell carcinoma after definitive radiation therapy: A multicenter retrospective observational study in China from 2015 to 2016
Journal of the National Cancer Center 2023cited by 17position: middledoi
Benchmarking the CoW with the TopCoW Challenge: Topology-Aware Anatomical Segmentation of the Circle of Willis for CTA and MRA
PubMed 2023cited by 10position: middledoi
Prevalence of Malnutrition Among Adult Inpatients in China: A Nationwide Cross-Sectional Study
SSRN Electronic Journal 2023cited by 0position: middledoi
Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis
Therapeutic Advances in Medical Oncology 2022cited by 5position: middledoi
Clinical practice and outcome of radiotherapy for advanced esophageal squamous cell carcinoma between 2002 and 2018 in China: the multi-center 3JECROG Survey
Acta Oncologica 2021cited by 30position: middledoi
Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 Trial
International Journal of Radiation Oncology*Biology*Physics 2021cited by 24position: middledoi
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China
Radiation Oncology 2021cited by 11position: middledoi
Age plays an important role in the decision of definitive concurrent chemoradiotherapy (CCRT) for esophageal squamous cell carcinoma (ESCC): a propensity-score matched analysis of multicenter data (3JECROG R-02A)
Translational Cancer Research 2021cited by 4position: middledoi
Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A)
BMC Cancer 2020cited by 20position: middledoi
Stage III Esophageal Squamous Cell Carcinoma Patients With Three-Dimensional Conformal or Intensity-Modulated Radiotherapy: A Multicenter Retrospective Study
Frontiers in Oncology 2020cited by 9position: middledoi
Dose escalation of 3D radiotherapy is effective for esophageal squamous cell carcinoma: a multicenter retrospective analysis (3JECROG R-03)
Annals of Translational Medicine 2020cited by 4position: middledoi
[Prognostic analysis of definitive radiotherapy for early esophageal carcinoma(T1-2N0M0): a multi-center retrospective study of Jing-Jin-ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group].
PubMed 2020cited by 3position: middledoi
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: A multi-center study from China
Research Square 2020cited by 0position: middledoi
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: A multi-center study from China
Research Square 2020cited by 0position: middledoi
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: A multi-center study from China
Research Square 2020cited by 0position: middledoi
A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer – the 3JECROG P-01 study protocol
BMC Cancer 2019cited by 18position: middledoi
Correction to: A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer – the 3JECROG P-01 study protocol
BMC Cancer 2019cited by 4position: middledoi
Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A)
Research Square 2019cited by 0position: middledoi
Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data ( 3JECROG R-03A )
Research Square 2019cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xin Wang · China University of Mining and Technology10 papers (2019–2025) · 8 papers (2019–2025)Qingsong Pang · Tianjin Medical University Cancer Institute and Hospital8 papers (2019–2025)Chun Han · Hebei Medical University8 papers (2019–2025) · 8 papers (2019–2025)Xueying Qiao · Hebei Medical University6 papers (2019–2025)Yuanji Xu · Guangzhou University of Chinese Medicine6 papers (2024–2025)Xinchen Sun · Nantong University6 papers (2019–2021)Xiaolin Ge · Nanjing Medical University6 papers (2019–2025)Kaixian Zhang · Xuzhou Medical College5 papers (2019–2021)Kuaile Zhao · Shanghai Medical College of Fudan University5 papers (2023–2025)Gaofeng Li · Binzhou University5 papers (2019–2025)Wenbin Shen · Henan Institute of Technology5 papers (2024–2025)Mingqiu Chen · Soochow University4 papers (2019–2020) · 4 papers (2019–2025)Jinjun Ye · Guangzhou University of Chinese Medicine3 papers (2023–2025)Xiao‐Han Zhao · Shihezi University3 papers (2024–2025)Yatian Liu · Hebei Medical University3 papers (2024–2025)Xiaojie Xia · Jiangsu University3 papers (2024–2025)Chunyue Gai · Hebei Medical University3 papers (2024–2025)